ASCO Heard in the Halls: Bobby Hill on Biomarker Discovery & Precision Testing
HITea With GraceJune 22, 202600:02:53

ASCO Heard in the Halls: Bobby Hill on Biomarker Discovery & Precision Testing

Grace Vinton sits down with Bobby Hill, Senior Vice President and Chief Commercial Officer of Caris Life Sciences, live from ASCO.

Bobby captures the momentum on the floor this year: biomarker discovery and targeted therapies are advancing rapidly for patients in both early and late stage cancer, and the industry is moving at the speed of light to get patients the right answers, earlier.

Caris Life Sciences, in collaboration with the Precision Oncology Alliance and over 100 academic institutions, presented 32 posters at ASCO this year. A major theme: the critical importance of whole genome sequencing in getting the right patient on the right drug at the right time.

Bobby also digs into the power of tissue testing and how it comprehensively measures tumor mutation burden and detects cancer better than ever before. And perhaps most exciting? The combination of tissue and blood testing together is opening a new frontier for informing patient diagnostics and care.

The science is here. The tools are here. And patients are the ones who win.

Be sure to like and subscribe to HITea with Grace for honest conversations at the intersection of health, innovation, and technology!